Dr. Yvonne Saenger: Crushing Cancer’s Defenses
For about a decade, large clinical trials of cancer vaccine candidates have turned out mostly disappointing. But now a handful of new therapies are showing signs that the cancer vaccine effort could be on the brink of big breakthroughs. However, few melanoma vaccines have lived up to expectations, says Dr. Yvonne Saenger, a melanoma specialist at Mount Sinai School of Medicine in New York City. The drug MAGE-A3 may or may not be different, she says. She is waiting to see the Phase III results before weighing in. Learn more
Mount Sinai Scientists Create AI-Powered Tool to Improve Cancer Tissue Analysis
Aug 25, 2025 View All Press Releases
Combination Therapy Improves Outcomes for Advanced Triple-Negative Breast Cancer
Aug 21, 2025 View All Press Releases
Mount Sinai Researchers Engineer Rare Immune Cells to Create Powerful New Cancer Vaccine
Jul 21, 2025 View All Press Releases
Mount Sinai Study Advances Understanding of Personalized Vaccines for Bladder Cancer
May 12, 2025 View All Press Releases
Mount Sinai Researchers Discover How Melanoma May Spread to the Brain
Apr 30, 2025 View All Press Releases
Mount Sinai Showcases Innovative Cancer Research at 2025 AACR Annual Meeting in Chicago
Apr 24, 2025 View All Press Releases